Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17452677

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 May 20
First author
Moore MJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 May 20;25(15):1949-52. doi: 10.1200/JCO.2006.09.4664.
    note
    Source null
    related pmid
    17452675
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2007 Sep 20;25(27):4320-1; author reply 4321-2. doi: 10.1200/JCO.2007.12.8801.
    note
    Source null
    related pmid
    17878488
    relationship
    Comment in
  3. citation
    Nat Clin Pract Oncol. 2007 Dec;4(12):686-7. doi: 10.1038/ncponc0960.
    note
    Source null
    related pmid
    17895874
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508. doi: 10.1200/JCO.2007.13.0401.
    note
    Source null
    related pmid
    17906218
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2007 Dec 20;25(36):5836-7. doi: 10.1200/JCO.2007.14.6258.
    note
    Source null
    related pmid
    18089885
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2023 Oct 20;41(30):4714-4720. doi: 10.1200/JCO.22.02770.
    note
    Source null
    related pmid
    37847995
    relationship
    Republished in

Authors and identifiers

  1. name
    Moore MJ
    type
    Author
  2. name
    Goldstein D
    type
    Author
  3. name
    Hamm J
    type
    Author
  4. name
    Figer A
    type
    Author
  5. name
    Hecht JR
    type
    Author
  6. name
    Gallinger S
    type
    Author
  7. name
    Au HJ
    type
    Author
  8. name
    Murawa P
    type
    Author
  9. name
    Walde D
    type
    Author
  10. name
    Wolff RA
    type
    Author
  11. name
    Campos D
    type
    Author
  12. name
    Lim R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moore MJ
    type
    Author
  2. name
    Goldstein D
    type
    Author
  3. name
    Hamm J
    type
    Author
  4. name
    Figer A
    type
    Author
  5. name
    Hecht JR
    type
    Author
  6. name
    Gallinger S
    type
    Author
  7. name
    Au HJ
    type
    Author
  8. name
    Murawa P
    type
    Author
  9. name
    Walde D
    type
    Author
  10. name
    Wolff RA
    type
    Author
  11. name
    Campos D
    type
    Author
  12. name
    Lim R
    type
    Author
bibliography ids
  1. nci-bib-f4d1bbbb3c724648a49b7366
book metadata
content sha256
3f4a625acf688d7acc9453d6299a836898697e84c53e2db7fd1dd5d755d720c3
document type
citation
dois
  1. 10.1200/JCO.2006.07.9525
electronic publication date
display
2007 Apr 23
precision
day
year
2007
evidence scope
bibliographic_metadata_only
id
pubmed:17452677
immutable id
pubmed:17452677@3f4a625acf688d7acc9453d6299a836898697e84c53e2db7fd1dd5d755d720c3
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
15
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1960-6
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 May 20;25(15):1949-52. doi: 10.1200/JCO.2006.09.4664.
    note
    Source null
    related pmid
    17452675
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2007 Sep 20;25(27):4320-1; author reply 4321-2. doi: 10.1200/JCO.2007.12.8801.
    note
    Source null
    related pmid
    17878488
    relationship
    Comment in
  3. citation
    Nat Clin Pract Oncol. 2007 Dec;4(12):686-7. doi: 10.1038/ncponc0960.
    note
    Source null
    related pmid
    17895874
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508. doi: 10.1200/JCO.2007.13.0401.
    note
    Source null
    related pmid
    17906218
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2007 Dec 20;25(36):5836-7. doi: 10.1200/JCO.2007.14.6258.
    note
    Source null
    related pmid
    18089885
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2023 Oct 20;41(30):4714-4720. doi: 10.1200/JCO.22.02770.
    note
    Source null
    related pmid
    37847995
    relationship
    Republished in
outcomes validated
false
pmid
17452677
provenance
batch id
de363a11f4b1613edab0
provider
NCBI PubMed ESummary
record sha256
257890f6adabc85c58b8d4b750f3f05ac448d84487d66b7d5683c674ed7a879b
response sha256
a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
retrieved at
2026-09-09T23:46:14.107379+00:00
publication date
display
2007 May 20
precision
day
year
2007
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17452677/
title
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Preserved source evidence · Not medical advice